ADVANCED / METASTATIC SOLID TUMOR
Clinical trials for ADVANCED / METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED / METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED / METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests an experimental drug called MK-6837, given alone or with another drug (pembrolizumab), in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug sh…
Matched conditions: ADVANCED / METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Immune cell booster shows promise for Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new immune cell therapy (memory NK cells) combined with standard treatment for people with advanced solid tumors that have spread. The main goal is to check safety in a small group of 6 patients. If safe, more patients may be added to see if it help…
Matched conditions: ADVANCED / METASTATIC SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Radioactive therapy targets Hard-to-Treat cancers in new trial
Disease control OngoingThis phase 2 trial is testing a radioactive drug called 177Lu-PSMA in 83 people with advanced or metastatic cancers that show up on a PSMA PET scan. The drug is given intravenously every 8 weeks for up to 4 cycles. The main goals are to check safety and see if the treatment can c…
Matched conditions: ADVANCED / METASTATIC SOLID TUMOR
Phase: PHASE2 • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC